View in EDS HTML Full Text PDF Full Text

Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin.

Saved in:
Bibliographic Details
Title: Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin.
Authors: BAIN, V. G.1 (AUTHOR), LEE, S. S.2 (AUTHOR), PELTEKIAN, K.3 (AUTHOR), YOSHIDA, E. M.4 (AUTHOR), DESCHÊNES, M.5 (AUTHOR), SHERMAN, M.6 (AUTHOR), BAILEY, R.7 (AUTHOR), WITT‐SULLIVAN, H.8 (AUTHOR), BALSHAW, R.9 (AUTHOR), KRAJDEN, M.10 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Jul2008, Vol. 28 Issue 1, p43-50. 8p. 2 Charts, 3 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/j.1365-2036.2008.03705.x